1. Home
  2. NOVT

as of 03-10-2026 3:40pm EST

$123.35
+$0.75
+0.61%
Stocks Miscellaneous Industrial Machinery/Components Nasdaq

Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.

Founded: 1968 Country:
United States
United States
Employees: N/A City: BEDFORD
Market Cap: 4.9B IPO Year: 1999
Target Price: $133.00 AVG Volume (30 days): 393.4K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 1.47 EPS Growth: -16.95
52 Week Low/High: $98.27 - $149.95 Next Earning Date: 05-26-2026
Revenue: $521,290,000 Revenue Growth: 35.49%
Revenue Growth (this year): 8.71% Revenue Growth (next year): 6.47%
P/E Ratio: 89.12 Index: N/A
Free Cash Flow: 48.4M FCF Growth: -65.74%

Stock Insider Trading Activity of Novanta Inc. (NOVT)

Glastra Matthijs

Chief Executive Officer

Sell
NOVT Mar 2, 2026

Avg Cost/Share

$136.58

Shares

6,500

Total Value

$899,239.12

Owned After

63,261

Buckley Robert

Chief Financial Officer

Sell
NOVT Feb 20, 2026

Avg Cost/Share

$142.14

Shares

1,423

Total Value

$200,466.76

Owned After

93,814

SEC Form 4

Form 1 Form 2
Glastra Matthijs

Chief Executive Officer

Sell
NOVT Feb 10, 2026

Avg Cost/Share

$145.04

Shares

7,500

Total Value

$1,087,800.00

Owned After

63,261

SEC Form 4

Glastra Matthijs

Chief Executive Officer

Sell
NOVT Feb 2, 2026

Avg Cost/Share

$135.98

Shares

6,500

Total Value

$878,458.68

Owned After

63,261

SEC Form 4

Buckley Robert

Chief Financial Officer

Sell
NOVT Jan 21, 2026

Avg Cost/Share

$140.14

Shares

1,423

Total Value

$199,424.20

Owned After

93,814

SEC Form 4

Glastra Matthijs

Chief Executive Officer

Sell
NOVT Jan 21, 2026

Avg Cost/Share

$140.00

Shares

7,500

Total Value

$1,050,000.00

Owned After

63,261

SEC Form 4

Glastra Matthijs

Chief Executive Officer

Sell
NOVT Jan 9, 2026

Avg Cost/Share

$130.00

Shares

6,177

Total Value

$803,010.00

Owned After

63,261

SEC Form 4

Glastra Matthijs

Chief Executive Officer

Sell
NOVT Jan 8, 2026

Avg Cost/Share

$130.14

Shares

323

Total Value

$42,035.22

Owned After

63,261

SEC Form 4

Sell
NOVT Dec 22, 2025

Avg Cost/Share

$120.16

Shares

747

Total Value

$89,759.52

Owned After

0

SEC Form 4

Sell
NOVT Dec 15, 2025

Avg Cost/Share

$119.67

Shares

748

Total Value

$89,513.16

Owned After

0

SEC Form 4

Earnings Transcripts

SEC 8-K filings with transcript text

View All
2025
Q4

Q4 2025 Earnings

8-K BUY

Feb 23, 2026 · 100% conf.

AI Prediction BUY

1D

+1.16%

$144.04

5D

+5.59%

$150.34

20D

+4.64%

$148.98

Price: $142.38 Prob +5D: 100% AUC: 1.000
0001193125-26-064191

8-K

false000107693000010769302026-02-232026-02-230001076930us-gaap:CommonStockMember2026-02-232026-02-230001076930novt:SixPointFiveZeroPercentTangibleEquityUnitsMember2026-02-232026-02-23

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2026

NOVANTA INC.

(Exact name of registrant as specified in is charter)

New Brunswick, Canada

001-35083

98-0110412

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

125 Middlesex Turnpike Bedford, Massachusetts

01730

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (781) 266-5700 Not Applicable (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common shares, no par value

NOVT

The Nasdaq Global Select Market

6.50% Tangible Equity Units

NOVTU

The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition. On February 23, 2026, Novanta Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter and full year December 31, 2025. A copy of this press release is attached hereto as Exhibit 99.1. The information contained in this Current Report, including Exhibit 99.1, is furnished under this Item 2.02 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any filing thereunder or under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits.

Exhibit Number

Description

99.1

Press Release, dated February 23, 2026

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Novanta Inc.

Date: February 23, 2026

By:

/s/ Robert J. Buckley

Robert J. Buckley

Chief Financial Officer

2025
Q3

Q3 2025 Earnings

8-K

Nov 3, 2025

0001193125-25-262744

8-K

false000107693000010769302025-11-032025-11-03

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2025

NOVANTA INC.

(Exact name of registrant as specified in is charter)

New Brunswick, Canada

001-35083

98-0110412

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

125 Middlesex Turnpike Bedford, Massachusetts

01730

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (781) 266-5700 Not Applicable (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common shares, no par value

NOVT

Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition. On November 3, 2025, Novanta Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended September 26, 2025. A copy of this press release is attached hereto as Exhibit 99.1. The information contained in this Current Report, including Exhibit 99.1, is furnished under this Item 2.02 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any filing thereunder or under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits.

Exhibit Number

Description

99.1

Press Release, dated November 3, 2025

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Novanta Inc.

Date: November 3, 2025

By:

/s/ Robert J. Buckley

Robert J. Buckley

Chief Financial Officer

2025
Q2

Q2 2025 Earnings

8-K

Aug 5, 2025

0000950170-25-102416

8-K

0001076930false00010769302025-08-052025-08-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2025

NOVANTA INC.

(Exact name of registrant as specified in is charter)

New Brunswick, Canada

001-35083

98-0110412

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

125 Middlesex Turnpike Bedford, Massachusetts

01730

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (781) 266-5700 Not Applicable (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common shares, no par value

NOVT

Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition. On August 5, 2025, Novanta Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended June 27, 2025. A copy of this press release is attached hereto as Exhibit 99.1. The information contained in this Current Report, including Exhibit 99.1, is furnished under this Item 2.02 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any filing thereunder or under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits.

Exhibit Number

Description

99.1

Press Release, dated August 5, 2025

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Novanta Inc.

Date: August 5, 2025

By:

/s/ Robert J. Buckley

Robert J. Buckley

Chief Financial Officer

Latest Novanta Inc. News

NOVT Breaking Stock News: Dive into NOVT Ticker-Specific Updates for Smart Investing

All NOVT News

Share on Social Networks: